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man genetics is more about keeping the shop closed than 
serving the public’s health.
 However, things are beginning to change. The innova-
tion of the internet has paved the way for the success of 
social networks in which citizens (including patients!) 
now have direct access to information and contact with 
people who share their problems and beliefs. In this edi-
torial the expression ‘citizen’ is used in its meaning of the 
French ‘citoyen’, i.e. the politically mature and responsi-
ble citizen. This democratization of information poses a 
threat to many health professionals by challenging their 
expertise. The argument that there is a lot of ‘garbage’ on 
the internet is a valid one, but whose job is it to separate 
one bit of information from the other? In addition, what 
information is useful to the person at what time for what 
purpose?
 If not the citizen herself or himself, who else can de-
cide? Here health literacy (HL) comes in. The ability to 
access, understand, appraise, and apply health informa-
tion – the four dimensions of HL  [2] – will be a corner-
stone for the citoyen of the future.
 The interest in HL is not only a ‘bottom-up’ movement 
empowering the citizen. Also governments would like to 
offer citizens more choices – even in healthcare. But how 
far can or should they go? That is one of the reasons why 
the European Commission has funded the development 
 It is difficult to implement an innovation. Often inno-
vations are neither desired nor welcomed at all. You in-
terfere with a status quo everybody seems to be happy and 
at terms with. Also, of course, it depends on the position 
or expectations you have regarding the innovation.  For 
example, there has been a strong and continuing resis-
tance from the medical profession to accept a nonmedical 
public health intervention for the prevention of sudden 
infant death (SIDS): simply putting babies in a supine po-
sition and avoiding a prone position instead of perform-
ing ‘fancy’ blood tests or having a medical intervention. 
Such a resistance prolongs the diffusion of an idea and 
thus the timely implementation of an innovation. In the 
case of SIDS in several European countries this took even 
more than 2 decades  [1] .
 Some approaches of the social sciences, on the other 
hand, still have reservations against innovations in the 
field of genomics per se, and persistently narrow genome-
based health information down to genetic tests for dread-
ful monogenic diseases.  The same arguments applied 
against the use of genome-based information are now, for 
instance, used in the discussion of nanotechnologies.  But 
also professional bodies play an important role here: the 
idea that any genomic test – even for multifactorial dis-
eases which are always based on genome-environment 
interactions – should be performed by a specialist in hu-
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of a HL survey to obtain an overview of the status quo of 
HL in Europe. Public health experts are often convinced 
that you should not even think of offering choices as citi-
zens cannot judge regarding difficult things such as 
‘health and diseases’. However, real life is different. In 
most areas of life we make decisions under uncertainty: 
which pension plan or which life insurance shall we 
choose, which job shall we take, or even which partner 
shall we marry?
 In the context of public health genomics this has seri-
ous implications. Dealing with a highly innovative and 
dynamic field of science that aims to prepare society for 
the future does not make the situation easier. It is quite 
obvious that all of the already mentioned hindering fac-
tors can be observed, but in addition what is new and even 
more challenging is the free direct access to genome-
based information, respectively genetic tests, of the citi-
zen and consumer. This puts the citizen, and no longer 
the researcher or the physician, in the driver’s seat. Hence, 
any investment in HL will contribute to a responsible 
translation of genome-based health information and re-
lated technologies for the citizen. This implies that we 
should not regulate everything to protect the ignorant 
consumer  [3] . We should rather concentrate on regula-
tions related to health protection as in the area of toxi-
cogenomics. Finally, this would put limits to public health 
paternalism, too.
 We would eventually move from the one-dimensional 
‘informed consent’ via ‘informed choice’ to ‘shared deci-
sion making’ and then on to ‘personal (‘myself ’) decision 
making’ as we have learned from the success story of the 
self-help movement. Citoyens would create their own 
personal data warehouse of health information keeping 
it, for example, on a USB stick and will not just leave this 
issue to health professionals.  As in the context of public 
health genomics the useful and personal health informa-
tion will change over the whole life course, so will HL  [4] . 
It will be a lifelong learning exercise, and it will change 
the citizens’ role from being passive to active or from be-
ing a consumer to being a prosumer as well as a citoyen.
 Might there be harm? What about the issue of assuring 
not only the ‘right to information’ but also an obligation 
to be informed? Where are the boundaries?  Maybe that is 
why the citizen will always demand and need some help 
from experts. However, this kind of support will be more 
in the form of assistance, leaving behind paternalistic de-
cision making for the citizen. Let’s make public health 
genomics a success story by accompanying it with HL 
measures! 
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